FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 2.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,506,186 | -14.9% | 466,869 | 0.0% | 2.56% | +10.9% |
| Q2 2023 | $4,122,453 | +6.1% | 466,869 | 0.0% | 2.31% | -10.0% |
| Q1 2023 | $3,884,350 | +27.7% | 466,869 | +47.3% | 2.57% | +5.3% |
| Q4 2022 | $3,042,710 | +98.0% | 316,949 | +67.0% | 2.44% | +198.8% |
| Q3 2022 | $1,537,000 | +45.1% | 189,750 | 0.0% | 0.82% | +58.4% |
| Q2 2022 | $1,059,000 | -0.4% | 189,750 | 0.0% | 0.52% | +15.5% |
| Q1 2022 | $1,063,000 | +27.3% | 189,750 | 0.0% | 0.45% | +112.4% |
| Q4 2021 | $835,000 | -49.3% | 189,750 | +8.6% | 0.21% | -64.0% |
| Q3 2021 | $1,646,000 | +86.8% | 174,750 | +44.6% | 0.58% | +18.7% |
| Q2 2021 | $881,000 | – | 120,851 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |